Delivery Order SPE2DB20D1100-SPE2DB24FA7C7

Award Date 3/13/24
Potential Completion Date 3/14/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564034116 - Bupropion HCL XL 300 mg Tablets in 500 count packages. The contract has a ceiling value of $5,364.72 and a performance period through March 22, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00 indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,981,495 units of Bupropion HCl XL 300 mg tablets. The $3,363.79 contract has a period of performance through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide 500 units of BUPROPION HCL XL 300 MG TABLET. The contract has a total potential value of $5,376.14 and a completion date of February 5, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $31,989.14 delivery order contract is for the supply of 4564327587 - Bupropion HCL XL 300 mg Tablets, 500 count. The contract has an ultimate completion date of April 19, 2024 and is a firm fixed price arrangement. Amerisourcebergen, a major pharmaceutical distribution company, is delivering these prescription medications under an Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,249,928 bupropion HCL XL 300 mg tablets in 500-count bottles. The $2,160 contract has an ultimate completion date of April 12, 2024 and is not set aside for any specific business type. Amerisourcebergen Drug Corp, the prime contractor, is the sole awardee on this delivery order, which is issued against a...
This federal contract award, valued at $13,575.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4563654049 - BUPROPION HCL XL 300 MG TABLET 500S, with an ultimate completion date of February 14, 2024. The contract is a firm fixed-price award and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,876.60, is for the delivery of Bupropion HCL XL 300 mg tablets and is a firm fixed-price delivery order with a completion date of May 1, 2024. The contract is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $1,814.29, is for the supply of Bupropion HCL XL 300 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $31,648.98 firm fixed price delivery order is for the provision of 4564159083 - BUPROPION HCL XL 300 MG TABLET 500S. The award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was previously awarded to Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $2,303.64 to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation. The contract is to provide 4564006464 - Bupropion HCL XL 300 mg tablets in 500-count containers. The delivery order contract has a performance period through March 20, 2024 and does not have a set-aside designation. This delivery order is issued under a larger indefinite...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA7C7
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4563955517 - Bupropion HCl XL 300 mg Tablets in 500-count bottles. The contract is a firm fixed price delivery order with a ceiling value of $14,784.85 and a period of performance through March 14, 2024. No set-aside designation was used for this award.

Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was issued under that IDC.

Generated 6/12/24, 9:45 AM